New enzyme-linked immunosorbent assay for detection of antibodies against hepatitis delta virus using a hepatitis delta antigen derived from a Taiwanese clone and comparison to the Abbott radioimmunoassay

Clin Vaccine Immunol. 2012 May;19(5):817-9. doi: 10.1128/CVI.05687-11. Epub 2012 Mar 7.

Abstract

An anti-hepatitis delta (HD) enzyme-linked immunosorbent assay (ELISA) using a specific recombinant hepatitis delta antigen derived from a local dominant hepatitis delta virus (hepatitis D virus; HDV) strain in Taiwan has been established. The detection efficiency of this assay was comparable to that of the commercially available Abbott anti-HD radioimmunoassay (RIA) and could be useful in routine laboratory diagnoses of HDV infection.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Laboratory Techniques / methods*
  • Enzyme-Linked Immunosorbent Assay / methods
  • Hepatitis Antibodies / blood*
  • Hepatitis D / diagnosis*
  • Hepatitis Delta Virus / immunology*
  • Hepatitis delta Antigens
  • Humans
  • Radioimmunoassay / methods
  • Recombinant Proteins
  • Taiwan

Substances

  • Hepatitis Antibodies
  • Hepatitis delta Antigens
  • Recombinant Proteins